ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Allarity Therapeutics Inc

Allarity Therapeutics Inc (ALLR)

0.167
0.0005
( 0.30% )
Updated: 11:06:29

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.167
Bid
0.1661
Ask
0.1681
Volume
54,036,161
0.1625 Day's Range 0.21
0.1421 52 Week Range 69.00
Market Cap
Previous Close
0.1665
Open
0.21
Last Trade
1000
@
0.167
Last Trade Time
11:06:29
Financial Volume
$ 10,214,077
VWAP
0.189023
Average Volume (3m)
7,423,550
Shares Outstanding
17,606,739
Dividend Yield
-
PE Ratio
-0.15
Earnings Per Share (EPS)
-1.16
Revenue
-
Net Profit
-20.42M

About Allarity Therapeutics Inc

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Allarity Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALLR. The last closing price for Allarity Therapeutics was $0.17. Over the last year, Allarity Therapeutics shares have traded in a share price range of $ 0.1421 to $ 69.00.

Allarity Therapeutics currently has 17,606,739 shares outstanding. The market capitalization of Allarity Therapeutics is $2.93 million. Allarity Therapeutics has a price to earnings ratio (PE ratio) of -0.15.

ALLR Latest News

Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares

Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...

Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives

  Current Cash Balance of $20 million Expected to Provide Runway Into 2026Allarity to Pause Use of ATMCap Table Successfully Cleaned UpAllarity’s Stenoparib Shows Extended Duration of Phase 2...

Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance

Boston (June 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...

Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer

Multiple patients have now exceeded 30 weeks on treatment Boston (June 25, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-19.32367149760.2070.24840.1421172383400.17209823CS
4-0.043-20.47619047620.210.24840.142175803910.18390165CS
12-1.103-86.85039370081.273.460.142174235500.60671517CS
26-8.473-98.06712962968.649.60.142137923830.93074483CS
52-59.433-99.719798657759.6690.142123836334.76438005CS
1562220700.83825-100.00000752-2220700.67125123520-1484398.551871837101-14712.7134516CS
2602220700.83825-100.00000752-2220700.67125123520-1484398.551871837101-14712.7134516CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 2.9816
(189.48%)
76.64M
DRMADermata Therapeutics Inc
$ 2.7099
(108.45%)
52.77M
SLNASelina Hospitality PLC
$ 0.0509
(95.77%)
670.74M
QXOQXO Inc
$ 137.07
(72.85%)
76.59k
PIRSPieris Pharmaceuticals Inc
$ 13.58
(70.18%)
4.06M
NXTTNext Technology Holding Inc
$ 1.97
(-66.15%)
320.69k
NUWENewellis Inc
$ 2.60
(-37.35%)
680.87k
ATPCAgape ATP Corporation
$ 0.14
(-34.88%)
4.24M
VWEVintage Wine Estates Inc
$ 0.075
(-32.98%)
17.14M
CONNConns Inc
$ 0.375
(-26.04%)
2.14M
SLNASelina Hospitality PLC
$ 0.051
(96.15%)
670.84M
SGMOSangamo Therapeutics Inc
$ 0.5645
(40.67%)
168.49M
NVDANVIDIA Corporation
$ 118.00
(-3.74%)
81.52M
TSLATesla Inc
$ 217.33
(-11.79%)
77.41M
NUZENuZee Inc
$ 2.9999
(191.25%)
76.64M

ALLR Discussion

View Posts
trendzone trendzone 18 hours ago
Funny how they are trying to scare share holders into voting yes for a RS, mean while they screwed over any one who got stuck in the last one they just did in May, $5.00 to $0.15 in just three months,great investment only if you were short, or a naked shorting hedge fund criminal enterprise, wouldn't be surprised if they themselves shorted their own stock back then, sure they want a RS so they can keep the toxic slob formula in place,and keep their over paid salaries from getting hit and cut in half,and keep sucking money out of it on the backs of the public.
👍️0
Law of Averages Law of Averages 19 hours ago
I wonder if this will hit $1.00 it's moving pretty fast
👍️0
Awl416 Awl416 19 hours ago
8k was released
👍️0
Law of Averages Law of Averages 19 hours ago
Looks like a short squeeze has started after hours .27 and climbing
👍️0
georgie18 georgie18 21 hours ago
ALLR...18... https://schrts.co/AshjZBCw...Could get squeezed here with some tight bands...🥳
👍️0
Law of Averages Law of Averages 22 hours ago
BB bands are super tight on ALLR this could see a hard bounce up.
👍️0
TheOTCstocksGuy TheOTCstocksGuy 2 days ago
Absolute trash!! Been saying it for months but no one listens as usual!!
👍️0
gdog gdog 2 days ago
pretty much
👍️0
 just Scottie just Scottie 2 days ago
In the toilet now
👍️0
gdog gdog 2 days ago
ALLR recieves a well notice trade accordingly
👍️0
 just Scottie just Scottie 4 days ago
I haven’t been a shareholder long enough I guess. I didn’t get an email.
I guess to vote on the RS, stock options lol and new officers
👍️0
gdog gdog 4 days ago
gosh i don't know I usually just delete without looking much what does it look like?
👍️0
 just Scottie just Scottie 4 days ago
Did u get an email to vote for the split?
👍️0
gdog gdog 5 days ago
agree
👍️0
 just Scottie just Scottie 5 days ago
Getting an extension and postpone the split and get some good news is the only way we stave off the wolves
👍️0
 just Scottie just Scottie 5 days ago
Someone just said short shares are over $3 million
👍️0
gdog gdog 5 days ago
yup lets see how far they take it down am also done buying.
👍️0
 just Scottie just Scottie 5 days ago
I’m afraid to ave down again
Every time I have it plunges more
👍️0
 just Scottie just Scottie 5 days ago
Yes big time
👍️0
gdog gdog 5 days ago
lol i was typing as you were posting yes we need g/news
👍️0
gdog gdog 5 days ago
yes I'm down a good bit also we need good news and hurry
👍️0
 just Scottie just Scottie 5 days ago
Company needs to majorly combat this with some good news
👍️0
gdog gdog 5 days ago
that was ending 6-30
👍️0
gdog gdog 5 days ago
https://www.marketbeat.com/stocks/NASDAQ/ALLR/short-interest/
700,000 sold short in the last 2 wks
👍️0
 just Scottie just Scottie 5 days ago
They are doing a good job. Lost my ass
Doesn’t help if the company may be selling too
👍️0
gdog gdog 5 days ago
I added a few today gulp all markets down today. the shorts are trying to destroy it
👍️0
 just Scottie just Scottie 5 days ago
Selling is relentless brother. Where the hell does it all come from
👍️0
 just Scottie just Scottie 7 days ago
That will be great
👍️0
gdog gdog 7 days ago
understood still think buyout
👍️0
 just Scottie just Scottie 7 days ago
Well unfortunately they need to maintain a dollar to stay on the daq
👍️0
gdog gdog 7 days ago
17.5 m outstanding don't let people worry you about an RS
👍️0
 just Scottie just Scottie 7 days ago
Gonna be tough sledding here. So much downward pressure due to the RS threat
Shorts and pump and dumpers have the upper hand
👍️0
gdog gdog 7 days ago
few hundred isn't wwhat I'm looking for I wants k's
look https://investorshub.advfn.com/Bottom-Swing-Plays-29717
👍️0
 just Scottie just Scottie 7 days ago
Everyone dumped from 18 cents
Hoping news of new trial comes today
👍️0
gdog gdog 1 week ago
BUY out coming ??????????
👍️0
Law of Averages Law of Averages 1 week ago
Agreed. ALLR moving up hella quick.
👍️0
 just Scottie just Scottie 1 week ago
Shorty could shit themselves here soon.
👍️ 1
Zardiw Zardiw 1 week ago
Stop sugar coating it.......say it like it is...........

Z
👍️0
 just Scottie just Scottie 1 week ago
$ALLR THESE PARTS OF THE LAST PR STAND OUT TO ME. TELLS ME THEY ARE ACTIVELY LOOKING FOR PARTNERS OR BUYOUT. THEY HAVE GOTTEN VERY GOOD RESULTS, SO GOOD THEY STOPPED THE LAST TRIAL EARLY. YOU DON’T DO THAT UNLESS THE PATIENTS HAVE BENIFITTED. FDA COULD COME I AND FAST FRACK THIS. ITS JUST MEANT TO EXTEND LIFE ON ADVANCED OVARIAN CANCER PATIENTS. SOFAR THEY HAVE PROVED IT SHRINKS TUMOR SIZE.
“Not only does the safety profile stand out when compared to chemotherapies, which is often the alternative for this patient group, but the safety metrics are indeed also favorable when compared to first-generation PARP inhibitors. As we see it, stenoparib may represent the next-generation alternative for advanced ovarian cancer patients. Therefore, we are aggressively working with Dr. Moore and other leading experts to design a trial that will help advance and quicken stenoparib’s clinical progress toward registration with the FDA.”

“After conducting a detailed review of the stenoparib monotherapy trial data, including the data announced today, the Company has concluded that these data may be of significant interest among key oncologists, potential commercial partners, and other relevant stakeholders and therefore warrant presentation within a high-level scientific conference. Further release of these clinical data is intended to be staged to comply with the common rules of scientific conferences, which do not allow data to be published before the event.”

The PARP inhibitor market is expected to reach $22 billion in revenue by 2028, and has historically seen significant partnerships and acquisitions.

For example, one significant acquisition included a multi-asset deal potentially totaling $1.5 billion, which featured an advanced PARP inhibitor.

Allarity has exclusive global rights for the development and commercialization of stenoparib, which was originally developed by Eisai Co. Ltd. and was formerly known under the names E7449 and 2X-121.


👍️0
TheOTCstocksGuy TheOTCstocksGuy 3 weeks ago
More trash stinking up the markets!! Get this POS delisted and out of here!!
👍️0
 just Scottie just Scottie 3 weeks ago
U too my man
👍️0
gdog gdog 3 weeks ago
Have a great 4th.
👍️0
 just Scottie just Scottie 3 weeks ago
I’m thinking the same especially if it’s got the FDA involved
👍️ 1
gdog gdog 3 weeks ago
still holding all I still believe this will run. the next trial will really make it fly if its favorable.
👍️0
 just Scottie just Scottie 3 weeks ago
Whatcha thinking on what is happening now bro?
👍️0
 just Scottie just Scottie 4 weeks ago
Agreed, i loaded today at 20 cents
👍️0
gdog gdog 4 weeks ago
I think the shorts are giving share holders a gift at these prices, if this passes Phase three ---- look out shorty
👍️0
 just Scottie just Scottie 4 weeks ago
Now would be a good time to throw everything and the kitchen sink to stabilize this and kill the short attack
👍️0
eyeownu eyeownu 4 weeks ago
IF the os/float is not increasing than it's nss. everyone is saying dilution. my only issue is why do they dilute at .30- 20 cents when they could do it much higher. maybe the said dilution volume is from the buyer. all imo
👍️0
 just Scottie just Scottie 4 weeks ago
Definitely shenanigans
If the RS shorts will attack and bring it down again
They need an alternative. Partnerships joint venture or buyout
👍️0

Your Recent History

Delayed Upgrade Clock